Meet This Issue's Contributors

, best known for leading the team that cloned Dolly, earned his PhD in 1971 for research that included work that led to the birth of Frosty, the first calf born from a frozen embryo.

| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

Ian Wilmut, best known for leading the team that cloned Dolly, earned his PhD in 1971 for research that included work that led to the birth of Frosty, the first calf born from a frozen embryo. Now a professor at the Roslin Institute, Edinburgh, Scotland, he will move later this year to the University of Edinburgh. He recently received a license from the UK government to clone human embryos, and on page 16 this issue, he writes about his intention to use stem cells from these embryos to develop research tools and therapies for motor neuron disease.

Ricki Lewis, who writes about nuclear reprogramming in cloning on page 12, has spent more than 20 years communicating science. Since receiving her PhD from Indiana University in 1980, she's penned thousands of articles for such publications as Nature, Discover, and book reviews for The New York Times. She's written four textbooks, is ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies